Cerity Partners’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
Cerity Partners's OTLK Position: Q3 2026 in Review
Cerity Partners opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 34,691 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #3405 among its holdings.
61 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.
- Cerity Partners held 34,691 shares of Outlook Therapeutics worth $19.9K as of Q3 2026.
- Outlook Therapeutics was a new Cerity Partners position in Q3 2026.
- Outlook Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #3405 holding.
- 61 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.
Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.